🇺🇸 calcium and cholecalciferol in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Atrioventricular Block — 1 report (10%)
  2. Blood Sodium Decreased — 1 report (10%)
  3. Bradycardia — 1 report (10%)
  4. Breast Cancer — 1 report (10%)
  5. Bronchial Carcinoma — 1 report (10%)
  6. Electrocardiogram Qt Prolonged — 1 report (10%)
  7. Fall — 1 report (10%)
  8. Hypokalaemia — 1 report (10%)
  9. Lacunar Infarction — 1 report (10%)
  10. Lobular Breast Carcinoma In Situ — 1 report (10%)

Source database →

calcium and cholecalciferol in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is calcium and cholecalciferol approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for calcium and cholecalciferol in United States?

Institut du Cancer de Montpellier - Val d'Aurelle is the originator. The local marketing authorisation holder may differ — check the official source linked above.